FAIR LAWN, N.J.--(BUSINESS WIRE)--Vyteris, Inc. (OTCBB: VYTR), an innovator in alternative drug delivery technology, announces that Gene E. Burleson (age 69) has been appointed to the Company’s Board of Directors effective December 1, 2010. Mr. Burleson is the first of two MediSync BioServices Directors to be named to the Vyteris Board under the September 2010 merger agreement.